Read the case analysis: Sycamore Pharmaceuticals on page 189-190. Write a two- to three- page paper (excluding title and reference pages) that addresses the following questions.
· What would you advise John Blake to do? Why? What are reasons both for and against being honest with the FDA?
· Do you believe it would take courage for Blake to honestly reveal the timing and content of the scientific studies? What sources of courage might he call upon to help him make his decision?